Aptevo Therapeutics (APVO) Current Leases (2024 - 2026)
Aptevo Therapeutics (APVO) posted Current Leases of $900000.0 for Q1 2026, up 3.93% sequentially from $866000.0 in Q4 2025, and up 12.5% YoY from $800000.0 in Q1 2025.
Aptevo Therapeutics (APVO) Current Leases (2024 - 2026) Analysis & Trends
Aptevo Therapeutics has reported Current Leases for 3 years, with the latest figure at $900000.0 in Q1 2026.
- Quarterly Current Leases rose 12.5% year-over-year to $900000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $900000.0 (up 12.5% YoY) and the FY2025 annual result came in at $866000.0, up 12.76% from the prior year.
- Current Leases climbed to $900000.0 in Q1 2026 per APVO's latest filing, from $866000.0 in the prior quarter.
- Over five years, Current Leases peaked at $900000.0 in Q1 2026 and troughed at $768000.0 in Q4 2024.
- A 3-year average of $833500.0 and a median of $833000.0 in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases climbed 12.76% in 2025, then gained 12.5% in 2026.
- Over 3 years, Current Leases stood at $768000.0 in 2024, then advanced by 12.76% to $866000.0 in 2025, then advanced by 3.93% to $900000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $900000.0, $866000.0, and $800000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | 919,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 919,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 866,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 768,000.00 |